http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2449285-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23d557c2515310707735924414b39eec
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
filingDate 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c17d5e9a332be26e2fc301ebaf02a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1d7f4f9c7c9c672ef3afd980d3f075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_092a3589b73a8b3f1e305eef213d25f8
publicationDate 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2449285-C1
titleOfInvention Method of predicting risk of arterial hypertension development in patients with primary osteoarthrosis
abstract FIELD: medicine. n SUBSTANCE: invention can be used for prediction of risk of development of arterial hypertension in patients with primary osteoarthrosis (POA). Invention is based on determination of duration in years (DKS) and intensity (VASH) of pain syndrome, calculation of number of desquamated endotheliocytes in blood (DEC) with further calculation of coefficient by formula K= DKS*DEC*VASH)/100. If coefficient value is more than 1, conclusion about high risk of arterial hypertension development is made. If coefficient value is lower than 1, probability of AH development is relatively low. n EFFECT: application of the method makes it possible to predict development of AH in said category of patients with high reliability and take adequate prophylactic and therapeutic measures in due time. n 2 tbl, 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2558990-C1
priorityDate 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2287158-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2188430-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID692510
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO61608
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9I9M2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO61309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8T8C0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34495
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4328006

Total number of triples: 28.